This site is intended for healthcare professionals
  • Home
  • /
  • News
  • /
  • 2011
  • /
  • 09
  • /
  • Absorb bioresorbable vascular scaffold in Critical...
Drug news

Absorb bioresorbable vascular scaffold in Critical Limb Ischaemia

Read time: 1 mins
Last updated:17th Sep 2011
Published:17th Sep 2011
Source: Pharmawand
Abbott initiates ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the Absorb bioresorbable vascular scaffold for the treatment of below-the-knee critical limb ischemia. Critical limb ischemia, a severe form of peripheral artery disease occurs when blocked vessels impair blood flow to the lower extremities, which can eventually lead to limb amputation. Absorb restores blood flow by opening a blocked vessel and providing support to the vessel until the device dissolves within approximately two years.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.